These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11485082)

  • 21. [Effect of amino acid substitutions in the gp120 V3-loop sequence on serological cross-reactivity between various HIV-1 subtypes].
    Iaroslavtseva NG; Shchelkanov MIu; Iudin AN; Navruzbekov GA; Semiletov IuA; Karamov EV
    Mol Biol (Mosk); 1997; 31(2):338-43. PubMed ID: 9213763
    [No Abstract]   [Full Text] [Related]  

  • 22. [Establishment of a double-antigen sandwich ELISA for detecting total antibodies to human immunodeficiency virus type 1/2].
    He H; Mao P; Hou J; Hong S; Zhu L; Hu Y; Bai Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):288-91. PubMed ID: 12665944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new combined HIV p24 antigen and anti-HIV-1/2/O screening assay.
    Polywka S; Duttmann H; Lübben F; Laufs R; Feldner J
    Methods Mol Biol; 2005; 304():229-43. PubMed ID: 16061980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of two rapid tests for the detection of HIV-1/HIV-2 antibodies.
    Myrmel H; Holm-Hansen C; Haukenes G
    AIDS; 1990 Nov; 4(11):1164-6. PubMed ID: 2282196
    [No Abstract]   [Full Text] [Related]  

  • 25. Mother to child transmission of HIV-1 in a Thai population: role of virus characteristics and maternal humoral immune response.
    Kittinunvorakoon C; Morris MK; Neeyapun K; Jetsawang B; Buehring GC; Hanson CV
    J Med Virol; 2009 May; 81(5):768-78. PubMed ID: 19319941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.
    Garrido C; Roulet V; Chueca N; Poveda E; Aguilera A; Skrabal K; Zahonero N; Carlos S; García F; Faudon JL; Soriano V; de Mendoza C
    J Clin Microbiol; 2008 Mar; 46(3):887-91. PubMed ID: 18199789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limited cross-reactivity between different HIV-1 clades.
    Mthunzi P; Meyer D
    J Clin Virol; 2004 Dec; 31 Suppl 1():S88-91. PubMed ID: 15567099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary results of HIV screening in sentinel facilities in Romania.
    Cernescu C; Popescu A; Tîrdei G; Alexandrescu R; Ruţă SM
    Rev Roum Virol; 1993; 44(3-4):171-3. PubMed ID: 7826867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of the circulating anti-HIV-1 gp120-specific B cell repertoire using antibody phage display libraries generated from pre-selected HIV-1 gp120 binding PBLs.
    Koefoed K; Farnaes L; Wang M; Svejgaard A; Burton DR; Ditzel HJ
    J Immunol Methods; 2005 Feb; 297(1-2):187-201. PubMed ID: 15777942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High specificity of V3 serotyping among human immunodeficiency virus type-1 subtype C infected patients with varying disease status and viral phenotype.
    Walker PR; Cilliers T; Choge IA; Taylor N; Cohen SS; Morris L
    J Med Virol; 2006 Oct; 78(10):1262-8. PubMed ID: 16927278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotyping HIV-1 with V3 peptides: detection of high avidity antibodies presenting clade-specific reactivity.
    Casseb J; Katzenstein D; Winters M; Brigido LF; Duarte AJ; Hendry RM
    Braz J Med Biol Res; 2002 Mar; 35(3):369-75. PubMed ID: 11887216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A serological screening assay of human immunodeficiency virus type 1 antibodies based on recombinant protein p24-gp41 as a fusion protein expressed in Escherichia coli.
    Mahboudi F; Irina NA; Chevalier A; Ghadiri A; Adeli A; Amini-Bavil-Olyaee S; Barkhordari F; Farzamfar B; Alinejad M
    J Biotechnol; 2006 Sep; 125(2):295-303. PubMed ID: 16647775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
    Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays?
    Ly TD; Ebel A; Faucher V; Fihman V; Laperche S
    J Virol Methods; 2007 Jul; 143(1):86-94. PubMed ID: 17395277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamics of the HIV-1 variability in adults from Bucharest, 1992-1998.
    Chiţu V; Diaconu CC; Veliceasa D; Ruţă S; Grancea C; Târdei G; Cernescu CE
    Rom J Virol; 1999; 50(1-4):43-51. PubMed ID: 11601379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of United States-licensed human immunodeficiency virus immunoassays for detection of group M viral variants.
    Koch WH; Sullivan PS; Roberts C; Francis K; Downing R; Mastro TD; Nkengasong J; Hu D; Masciotra S; Schable C; Lal RB
    J Clin Microbiol; 2001 Mar; 39(3):1017-20. PubMed ID: 11230420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of four commercial enzyme-linked immunosorbent and one agglutination assays for the detection of HIV antibodies in sera from Zimbabwe.
    Tswana SA; Moyo SR; Nyström L; Blomerg J
    Cent Afr J Med; 1993 Oct; 39(10):198-201. PubMed ID: 8020073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
    Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance evaluation of the new fully automated human immunodeficiency virus antigen-antibody combination assay designed for blood screening.
    Sickinger E; Jonas G; Yem AW; Goller A; Stieler M; Brennan C; Hausmann M; Schochetman G; Devare SG; Hunt JC; Kapprell HP; Bryant JD
    Transfusion; 2008 Apr; 48(4):584-93. PubMed ID: 18194389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The risk of a second diagnostic window with 4th generation HIV assays: Two cases.
    Niederhauser C; Ströhle A; Stolz M; Müller F; Tinguely C
    J Clin Virol; 2009 Aug; 45(4):367-9. PubMed ID: 19546027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.